Turn Therapeutics (TTRX) Non-cash Items (2024 - 2026)
Turn Therapeutics' quarterly Non-cash Items came in at $1.6 million in Q1 2026, down 79.79% quarter-over-quarter from $8.1 million in Q4 2025.
Turn Therapeutics has reported Non-cash Items for 3 years, with the latest figure at $1.6 million in Q1 2026.
- For the quarter ending Q1 2026, Non-cash Items changed N/A year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (changed N/A YoY), and the FY2025 full-year result was $8.1 million, up 108.3% from the prior year.
- Non-cash Items for Q1 2026 stood at $1.6 million, down from $8.1 million in the prior quarter.
- The five-year high for Non-cash Items was $8.1 million in Q4 2025, with the low at $1.6 million in Q3 2025.
- Average Non-cash Items over 3 years is $3.8 million, with a median of $2.8 million recorded in 2024.
- Peak annual rise in Non-cash Items reached 108.3% in 2025, while the deepest fall reached 108.3% in 2025.
- Tracing TTRX's Non-cash Items over 3 years: stood at $3.9 million in 2024, then soared by 108.3% to $8.1 million in 2025, then sank by 79.79% to $1.6 million in 2026.
- The last three Non-cash Items figures came in at $1.6 million (Q1 2026), $8.1 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Turn Therapeutics | 188.06 Mn | 188.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.63 Mn |
| Mar 31, 2026 | 1.63 Mn |
| Dec 31, 2025 | 8.08 Mn |
| Dec 31, 2025 | 8.08 Mn |
| Sep 30, 2025 | 1.63 Mn |
| Sep 30, 2025 | 1.63 Mn |
| Dec 31, 2024 | 3.88 Mn |
| Dec 31, 2024 | 3.88 Mn |